304 related articles for article (PubMed ID: 35636571)
1. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
[TBL] [Abstract][Full Text] [Related]
2. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract][Full Text] [Related]
4. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
[TBL] [Abstract][Full Text] [Related]
5. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
6. Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.
Caballo M; Sanderink WBG; Han L; Gao Y; Athanasiou A; Mann RM
J Magn Reson Imaging; 2023 Jan; 57(1):97-110. PubMed ID: 35633290
[TBL] [Abstract][Full Text] [Related]
7. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
8. Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy.
Zeng Q; Ke M; Zhong L; Zhou Y; Zhu X; He C; Liu L
Acad Radiol; 2023 Aug; 30(8):1638-1647. PubMed ID: 36564256
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
10. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
[TBL] [Abstract][Full Text] [Related]
12. Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy.
Eun NL; Kang D; Son EJ; Youk JH; Kim JA; Gweon HM
Eur Radiol; 2021 Sep; 31(9):6916-6928. PubMed ID: 33693994
[TBL] [Abstract][Full Text] [Related]
13. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Chen X; Chen X; Yang J; Li Y; Fan W; Yang Z
J Comput Assist Tomogr; 2020; 44(2):275-283. PubMed ID: 32004189
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
15. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
16. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
17. Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Guo L; Du S; Gao S; Zhao R; Huang G; Jin F; Teng Y; Zhang L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884576
[TBL] [Abstract][Full Text] [Related]
18. Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms.
Zheng G; Peng J; Shu Z; Jin H; Han L; Yuan Z; Qin X; Hou J; He X; Gong X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):147. PubMed ID: 38512406
[TBL] [Abstract][Full Text] [Related]
19. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
[TBL] [Abstract][Full Text] [Related]
20. Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
Liang X; Yu X; Gao T
Eur J Radiol; 2022 May; 150():110247. PubMed ID: 35290910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]